ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1267

Perceived Stress During the COVID-19 Pandemic Independently Associates with Worse Patient-Reported Outcomes in Systemic Lupus Erythematosus (SLE)

Sarah Patterson1, Laura Trupin2, Kimberly DeQuattro1, Cristina Lanata1, Maria Dall'Era3, Jinoos Yazdany2 and Patricia Katz2, 1UCSF, San Francisco, CA, 2University of California, San Francisco, San Francisco, CA, 3Division of Rheumatology, University of California, San Francisco, CA

Meeting: ACR Convergence 2020

Keywords: Cohort Study, COVID-19, Patient reported outcomes, psychosocial factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster II: Comorbidities

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Causes and risk factors for variations in SLE disease activity and symptom severity are incompletely understood. Prior studies suggest a link between stressful life events (e.g. trauma), perceived stress, and greater disease severity. We examined whether (1) high levels of stress during the COVID-19 pandemic—both generalized and attributed to COVID-19—were associated with worse patient-reported outcomes (PROs) among patients with lupus, and (2) increases in perceived stress concurrent with the pandemic associated with increases in symptoms and/or incident SLE flares.

Methods: Participants, drawn from the California Lupus Epidemiology Study (CLUES), were ≥18 years old and met ACR criteria for SLE. Data derive from interviews conducted during the COVID-19 pandemic and study assessments during the prior year. General stress was measured using the 4-item Perceived Stress Scale (PSS, range 0-16). Scores in the top quartile were categorized as high stress. High stress from COVID-19 was assessed by asking whether it had caused “a great deal of stress or worry” and/or “the most stressful situation I have been through”. PROs included: self-report disease activity (SLE Activity Questionnaire, SLAQ), pain severity (scale 1-10), fatigue (PROMIS fatigue scale), cognitive function (PROMIS cognitive ability scale), and self-report SLE flares (prior month). Multivariable linear and logistic regression first evaluated associations of generalized and COVID-19-specific stress with PROs during the pandemic while controlling for potential confounders (age, sex, race, education, income, smoking, disease duration, and disease damage), and then modeled changes in PROs from pre-pandemic to during the pandemic as a function of change in perceived stress (by PSS). We calculated adjusted means for each outcome based on the multivariable regression.

Results: The sample (n=201) was 91% female; 36% white, 27% Asian, 24% Hispanic, and 9% African American; mean age 50 (± 14) years; 17% with poverty-level income; and mean disease duration 22 (± 10) years. During the COVID-19 pandemic, 29% reported severe stress related to the health crisis. The mean PSS score in the high stress group was 10.1 (± 1.4), compared with 4.4 (± 2.6) among the rest of the cohort. In the cross-sectional multivariate regression model, high stress by both measures (PSS and COVID-19 stress question) was associated with worse scores for each PRO: greater self-reported disease activity, more pain, more fatigue, lower cognitive function, and higher frequency of flares (Table 1). In the longitudinal analysis, increase in stress independently associated with an increase in disease activity, increase in fatigue, and decrease in cognitive function, but no significant change in pain severity or flares (Table 2).

Conclusion: In a racially diverse SLE cohort, psychological stress during the COVID-19 pandemic independently associated with worse PROs including self-reported disease activity, fatigue, and cognitive dysfunction. Evidence-based non-pharmacologic interventions to bolster stress resiliency are urgently needed to improve outcomes in this patient population during the ongoing health crisis.

Table 1

Table 2


Disclosure: S. Patterson, None; L. Trupin, None; K. DeQuattro, None; C. Lanata, None; M. Dall'Era, Janssen, 5, AstraZeneca, 5; J. Yazdany, Eli Lilly, 1, Astra Zeneca, 1; P. Katz, None.

To cite this abstract in AMA style:

Patterson S, Trupin L, DeQuattro K, Lanata C, Dall'Era M, Yazdany J, Katz P. Perceived Stress During the COVID-19 Pandemic Independently Associates with Worse Patient-Reported Outcomes in Systemic Lupus Erythematosus (SLE) [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/perceived-stress-during-the-covid-19-pandemic-independently-associates-with-worse-patient-reported-outcomes-in-systemic-lupus-erythematosus-sle/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/perceived-stress-during-the-covid-19-pandemic-independently-associates-with-worse-patient-reported-outcomes-in-systemic-lupus-erythematosus-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology